Related Experiment Video

Updated: Nov 26, 2025

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.5K

Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer

Kumar Nikhil1, Hanan S Haymour1, Mohini Kamra1

  • 1Department of Chemistry and Purdue University Center for Cancer Research, 560 Oval Drive, West Lafayette, IN, 47907, USA.

British Journal of Cancer
|December 14, 2020
PubMed
Abstract

Insights

The study reveals LIMK2 degrades SPOP, a key tumor suppressor in prostate cancer (PCa). Inhibiting LIMK2 preserves SPOP, offering a new therapeutic strategy to halt PCa progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Speckle-type POZ protein (SPOP) acts as a tumor suppressor in prostate cancer (PCa) by degrading oncogenic substrates.
  • SPOP is frequently altered in PCa, but mechanisms for its downregulation in tumors with wild-type SPOP are unknown.
  • Prostate cancer progression to castration-resistant PCa (CRPC) occurs even with wild-type SPOP, suggesting other regulatory pathways exist.

Purpose of the Study:

  • To investigate the molecular mechanisms regulating SPOP levels in prostate cancer.
  • To identify novel interactions and pathways involved in SPOP downregulation during PCa progression.

Main Methods:

  • Utilized an innovative technique to identify SPOP as a direct target of LIMK2.
  • Employed biochemical assays to analyze the reciprocal relationship between SPOP and LIMK2.
  • Conducted in vivo xenograft studies to validate findings.

Main Results:

  • LIMK2 directly degrades SPOP through phosphorylation at three specific sites.
  • SPOP promotes LIMK2 ubiquitylation, establishing a negative feedback loop.
  • Degradation of SPOP by LIMK2 stabilizes oncogenic proteins AR, ARv7, and c-Myc, promoting PCa progression.
  • Phospho-resistant SPOP demonstrated complete suppression of tumorigenesis in vivo.

Conclusions:

  • LIMK2-mediated degradation of SPOP is a critical event in prostate cancer progression.
  • Targeting LIMK2 offers a therapeutic strategy to preserve wild-type SPOP function.
  • Inhibiting LIMK2 can potentially halt disease progression in prostate cancer.

More Related Videos

Phosphopeptide Analysis of Rodent Epididymal Spermatozoa09:30

Phosphopeptide Analysis of Rodent Epididymal Spermatozoa

Published on: December 30, 2014

13.2K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

577

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.3K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.0K